Stopping antipsychotics in patients with dementia reduces risk of fracture and delirium The study’s lead author said the “findings provide reassurance” that stopping long-term antipsychotic treatment when no longer needed prevents harms.…
‘Stark lack of government response’ on valproate redress, patient safety commissioner says In her annual report for 2025/2026, Henrietta Hughes said the government was “yet to announce a redress scheme or a timeline for providing a substantive response to the recommendations” made in her previous report on patients harmed by sodium valproate.…
GPhC launches campaign on risk of fake online pharmacies following launch of oral semaglutide The General Pharmaceutical Council has created posters and videos to educate patients on how to spot a fake online pharmacy.…
Everything you need to know about GLP-1s for weight loss From semaglutide to tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use.…
Pharmacy regulator warns against promotion of prescription weight-loss medicines A notice has reminded businesses that they cannot advertise prescription-only medicines or prescription-only medical treatments to the public.…
Restarting psychotropics after a treatment break: patient considerations and the pragmatic approach How to support safe, person-centred re-initiation of antidepressants, antipsychotics and mood stabilisers.…
Health news round-up: endocrine research, binge eating on the pill and AI in the NHS The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Asda Pharmacy launches ‘judgement-free’ disposal scheme as access to unregulated medication rises One-quarter of GPs said they have encountered patients who require hospital care following complications associated with unregulated medicines.…
MHRA issues drug safety warning over ACE inhibitor side effect A drug safety warning has advised clinicians that ACE inhibitors should be halted immediately if a patient is suspected of presenting with angioedema during treatment.…
Regulator investigating pharmacists following report on gender prescribing at GP practice Exclusive: The General Pharmaceutical Council said it opened its investigation after a report revealed how “potential harm” had been caused to 78 children and young people seeking support for gender dysphoria or incongruence.…
